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ABSTRACT
Introduction The emergence of the novel respiratory 
SARS- CoV-2 and subsequent COVID-19 pandemic have 
required rapid assimilation of population- level data to 
understand and control the spread of infection in the 
general and vulnerable populations. Rapid analyses 
are needed to inform policy development and target 
interventions to at- risk groups to prevent serious health 
outcomes. We aim to provide an accessible research 
platform to determine demographic, socioeconomic and 
clinical risk factors for infection, morbidity and mortality 
of COVID-19, to measure the impact of COVID-19 on 
healthcare utilisation and long- term health, and to 
enable the evaluation of natural experiments of policy 
interventions.
Methods and analysis Two privacy- protecting 
population- level cohorts have been created and derived 
from multisourced demographic and healthcare data. 
The C20 cohort consists of 3.2 million people in Wales on 
the 1 January 2020 with follow- up until 31 May 2020. 
The complete cohort dataset will be updated monthly 
with some individual datasets available daily. The C16 
cohort consists of 3 million people in Wales on the 1 
January 2016 with follow- up to 31 December 2019. 
C16 is designed as a counterfactual cohort to provide 
contextual comparative population data on disease, health 
service utilisation and mortality. Study outcomes will: (a) 
characterise the epidemiology of COVID-19, (b) assess 
socioeconomic and demographic influences on infection 
and outcomes, (c) measure the impact of COVID-19 on 
short -term and longer- term population outcomes and (d) 
undertake studies on the transmission and spatial spread 
of infection.
Ethics and dissemination The Secure Anonymised 
Information Linkage- independent Information Governance 
Review Panel has approved this study. The study findings 
will be presented to policy groups, public meetings, 
national and international conferences, and published in 
peer- reviewed journals.
INTRODUCTION
Understanding and controlling the 
COVID-19 pandemic is a rapidly changing, 
complex issue that requires near real- time 
local data, analyses, modelling and multidis-
ciplinary team science to devise, implement 
and evaluate a wide variety of intersectoral 
and cross- sectoral interventions to minimise 
population harm.1
Strengths and limitations of this study
 ► Rapid access to multiple data sources on a complete 
population.
 ► Great variety of individual and household- level data 
on demography, disease status, morbidity, mortality 
and viral genomics to support a wide range of stud-
ies on the evolution of the epidemic in Wales.
 ► Ability to support hierarchical analyses at vary-
ing geographical units: private residences, care 
homes, educational settings and healthcare facil-
ities to examine spatial spread and transmission 
of SARS- CoV-2 to inform and evaluate targeting of 
interventions.
 ► However, routine data do not capture data on some 
important aspects, such as quality of life.
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As the pandemic evolves, a wide range of issues need 
to be considered including the spread of infection in the 
general and vulnerable populations; health service resil-
ience; indirect harm minimisation; and effectiveness of 
control policies and interventions.
Responding to this challenge, the Welsh Government 
created a COVID-19 Technical Advisory Group (TAG) 
to provide rapid assimilation of available evidence 
and guide analysis of data to inform policy develop-
ment and appraisal. Insight from linked data is seen as 
being essential to understand the evolving epidemic. 
TAG commissioned the support of analyses conducted 
through the Secure Anonymised Information Linkage 
(SAIL) Databank ( www. saildatabank. com) to formulate 
evidence and advice to underpin its work in responding 
to COVID-19.2–5 SAIL is a state of the art, remotely acces-
sible, privacy- protecting system, accredited under the 
Digital Economy Act. SAIL holds and provides access to 
linked de- identified data from multiple sources at indi-
vidual, household and multiple ecological levels, for the 
population of Wales. The SAIL Databank has previously 
supported numerous types of clinical and population 
studies, including cohorts, evaluations of natural exper-
iments and embedded trials.6–13
This paper describes the development of two 
population- based cohorts in Wales, derived from multiple 
data sources to provide near real- time, in- pandemic intel-
ligence and analytics to TAG in relation to the following 
broad objectives:
Primary objectives
1. Determine demographic, socioeconomic and clini-
cal risk factors for infection, morbidity and mortality- 
related to COVID-19.
2. Determine the risk of COVID-19 infection and out-
comes in occupational groups.
3. Measure the population impact of COVID-19 on 
healthcare utilisation.
Secondary objectives
1. Create a platform to enable the evaluation of policies 
and interventions aimed at controlling the epidemic, 
whether clinical or non- pharmaceutical in nature.
2. Provide access to these derived population- based co-
horts and linked data sources to organisation and peo-
ple with relevant skills and expertise within the National 
Health Service (NHS), academia and government.
METHODS
Study design and population
The cohorts were derived from de- identified linked data 
from the SAIL Databank. We created two population- 
based cohorts derived from multiple demographic and 
healthcare data sources (figure 1).
 ► The C20 cohort consists of all people alive and known 
to the NHS in Wales from the 1 January 2020 with 
follow- up until 31 May 2020. We include people who 
moved into or were born in Wales after 1 January 
2020. Follow- up data will be added prospectively and 
the C20 cohort will be updated on a monthly basis in 
line with a full month of coverage of available data. 
Linkage to other data sources is also available beyond 
Figure 1 Data linkage of multiple demographic and healthcare data sources used in the creation of two population- wide 
cohorts: C20 and C16. ADDD, Annual District Death Daily; ADDE, Annual District Death Extract; CAPD, Postponed Admitted 
Procedures; CARE, Care homes Index; CCDS, Critical Care Data Set; CDDS, Consolidated Death Data Source; CVSP, 
COVID-19 Shielded People list; CVST, KCL Zoe Symptom Tracker App; EDDD, Emergency Department Dataset Daily; EDDS, 
Emergency Department Data Set; ICNARC, Intensive Care National Audit & Research Centre; LIMS, Laboratory Information 
Management System; LSOA, Lower Layer Super Output Area; OPDW, Out Patient Dataset for Wales; PEDW, Patient Episode; 
PLASC, Pupil Level Annual School Census; SAIL, Secure Anonymised Information Linkage; SQL, Structured Query Language; 
WDSD, Wash Demographic Service Dataset; WIMD, Welsh Index of Multiple Deprivation; WLGP, Welsh Longitudinal General 
Practise; WRRS, Wales Results Reporting Service.
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the cohort end date where the frequency and quality 
of each data source allow its use. Some datasets are 
analysed daily.
 ► The C16 cohort includes all individuals living in Wales 
and known to the NHS on the 1 January 2016 with 
follow- up to 31 December 2019. C16 is designed to 
provide counterfactual and contextual comparative 
data on population health service utilisation and 
mortality rates.
Membership of both cohorts is based on the inclusion 
of a person’s residence in Wales, registered to a Welsh 
General Practice (GP), a free to use NHS system at the 
point of primary care registration in the UK (figure 2). 
This is recorded within the Wales Demographic Service 
Dataset (WDSD). People are censored by study endpoints 
or migration out of Wales.
Data sources
Baseline populations are created using the weekly updated 
WDSD, the monthly updated Office for National Statis-
tics (ONS) mortality registry data known as the Annual 
District Death Extract, two new COVID-19 daily data 
sources: the Consolidated Death Data Source created by 
NHS Wales Informatics Service (NWIS) and the Annual 
District Death Daily from ONS.
Anonymised linkage fields
Linkage fields are used to anonymously link between 
data sources in the SAIL Databank. SAIL uses a multiple 
encryption system in which a trusted third party, the NWIS, 
uniquely matches identities to an Anonymised Linkage 
Field (ALF) and residences to a Residential Anonymised 
Linkage Field (RALF) before uploading data to SAIL.2 3 14
Demographic data
The cohorts include the following variables: ALF, age, 
sex, date of death, date of movement out of Wales, RALF 
and Care Home Anonymised Linkage Fields (CHALFs) 
for older people at cohort inception. The CHALF was 
derived from a data extract from Care Inspectorate Wales 
in 2020 for all adult care home settings.8 Geographical 
variables associated with the RALF and CHALF include 
Lower layer Super Output Area (LSOA) 2011 bound-
aries that are small statistical areas containing around 
1500 people. LSOA 2011 has been mapped to the Welsh 
Index of Multiple Deprivation (WIMD) version 2019 
to derive deprivation quintiles; Welsh health board of 
residence; and urban/rurality categories.15 16 Using the 
Welsh Government’s Pupil- Level Annual School Census 
(PLASC), the school population can also be linked to the 
cohorts for analyses by the school network.17
In addition, permission has been granted to embed 
occupation and role categories from electronic staff 
records of all NHS health boards and trusts, local 
authority social care workers and education staff. For 
healthcare workers, the electronic staff records system 
used in all health boards and trusts (111 000) are cate-
gorised by whether roles involve direct patient care or 
not and by occupational groups: Additional Professional 
Scientific and Technical; Additional Clinical Service; 
Administrative and Clerical; Allied Health Professionals; 
Estates and Ancillary; Healthcare Scientist; Medical and 
Dental, Nursing and Midwifery Registered; and Students. 
Social care workers are registered (https:// socialcare. 
wales/) and grouped into social workers, child home 
workers and domiciliary care workers (estimated 32 000). 
Educational staff records (estimated 70 000) include cate-
gories for teachers, support and administrative staff. This 
information is collected from the annual School Work-
force Annual Census held by the Welsh Government.18 
Data on care home staff are collected as part of Public 
Health Wales (PHW) testing of all staff and residents and 
made available in SAIL through the standard Laboratory 
Information Management System dataset. Permission 
has also been granted to link 2011 ONS census fields on 
ethnicity, occupation, housing tenure, over- crowding and 
socioeconomic status (SES). Ethnicity codes are derived 
from multiple health and social data sources mapped to 
Census 2011 groupings.19
Health data
All hospital admissions, outpatient and emergency 
department attendances treated in NHS hospitals as well 
Figure 2 Flow diagram of the C20 cohort inclusion criteria. WDSD, Wales Demographic Service Dataset.
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as GP data on all diagnoses and treatments from SAIL 
providing practices (80% population coverage) are avail-
able for cohort participants.20 As of the beginning of 
2020, we have added:
 ► Daily GP respiratory and COVID-19 codes for 100% of 
Welsh GP practices.
 ► Daily COVID-19 antigen test results.
 ► Bi- weekly data on participants reporting symptoms 
through the King's College London/ZOE symptom 
tracking app.21
 ► Weekly critical care data from the Intensive Care 
National Audit and Research Centre.22 23
 ► Bi- weekly COVID-19 viral genomic variant call format 
data and viral lineage assignments from PHW.24
 ► Monthly community dispensing data from pharma-
cies providing NHS issued prescriptions, backdated to 
2016.25
Exposure variables and potential confounding factors
A number of exposure variables will be used to contextu-
alise the study primary outcomes, including age, sex, SES 
and clinical risk groups.
SES will be derived from WIMD with quintile 1 including 
the 20% most deprived areas, and also at individual/
household level from the 2011 Census using the following 
codes: approximated social grade (SCGPUK11), highest 
level of qualification (HLQPUK11) and National Statis-
tics Socioeconomic Classification.26
Clinical risk groups have been derived from those used 
in scientific papers:
 ► Predictors of influenza and COVID-19 outcomes.27 28
 ► Published phenotype (disease conditions) libraries 
including the 308 phenotypes created by the Cardio-
vascular disease research using linked bespoke studies 
and electronic health records (CALIBER) study.29
 ► Commonly used comorbidity indices (Charlson and 
Elixhauser).30 31
 ► Frailty indices (electronic Frailty Index for GP data 
and Hospital Frailty Risk Score).32–34
In order to compare and combine results with other 
studies, we will replicate the 19 clinical groups 
included in a similar study in Scotland.35
Microbiological testing data will be de- duplicated and 
used to generate case- data for standard case definitions, 
agreed at UK level where possible.
Body mass index will be categorised as <20, 20–24, 
25–29, 30–39, ≥40 kg/m2; and smoking status categorised 
into four groups: current smoker, non- smoker, ex- smoker 
and not recorded for patients with no data on smoking, 
replicated from a study carried out in Scotland.35
Statistical analysis
We will describe baseline characteristics for exposures 
and outcomes of interest using means, medians, propor-
tions, ORs and rate ratios with appropriate measures of 
dispersion. We will report on the prevalence of missing 
data by variable and use two- tailed hypothesis tests with a 
5% significance level.
Non- independence of observations measured over time 
or within associated clusters, for example, GP or house-
holds will be taken into account using random effects. 
We will use causal frameworks where causal relationships 
are implied.36 Hypotheses being tested will be stated in 
advance and plans will be drawn up for each research 
project. Analyses will primarily be conducted in the R 
statistical programming language.37 38
Analyses
We will test associations for demographic, socioeco-
nomic and clinical risk factors for COVID-19 infection 
and associated morbidity and mortality. COVID-19 infec-
tion will be defined in a number of ways: (a) positive 
SARS- CoV-2 laboratory antigen test; (b) clinical diagnosis 
of COVID-19 infection in GP records, intensive care, or 
hospital discharge records; (c) ONS mortality records 
listing COVID-19 as the underlying or contributory cause; 
and (d) positive serology report (when available).
Planned analyses include:
 ► Incidence of COVID-19 over time and by geography 
and demographic groups.
 ► Influence of area deprivation and individual SES 
metrics on infection and outcomes.
 ► Impact of COVID-19 on short- term (<6 months) and 
longer- term population outcomes such as changes 
in health service utilisation and excess, overall and 
disease- specific mortality.
 ► Description of the extent of clustering of cases within 
all available residential, educational, occupational 
and geographic units, thus providing signatures of 
spatial spread at defined levels, and between levels, 
thought to have played a crucial role in transmission.
We will investigate the relationship between health 
(physical and mental), socioeconomic and environ-
mental factors, such as self- rated health, limiting long- 
term illness, housing tenure, over- crowding, education 
status, and occupation on infection risk and outcome.
Changes in healthcare utilisation will be assessed by 
measuring differences preinfection and postinfection for: 
NHS111 telephone calls, GP consultations, emergency 
department attendances, hospital admissions and length 
of stay, and intensive care admissions.
Analytical techniques will include descriptive statistics, 
univariate and multivariate generalised linear mixed 
models, survival analyses and the use of self- controlled 
case series for temporary risk factors.39 Relationships 
between variables will be clarified before specific analyses.
Cohort characteristics
The C16 and C20 cohorts have been constructed from 
patients registered with all GPs in Wales (table 1).
The power to detect relevant outcomes will be assessed 
as the pandemic evolves. There are plans to collaborate 
with researchers across the UK and collating data from 
similar cohorts,35 to maximise power, support the eval-
uation of natural experiments in policy and its timing 
around disease control, and exit strategies from the 
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lockdown on physical restrictions that commenced on 23 
March 2020.
The individual datasets that comprise the cohorts are 
held on the globally accessible SAIL Databank available 
to accredited researchers.
Proposed future developments
As the pandemic evolves so will policies and practices to 
control the epidemic and mitigate negative consequences. 
As these develop, we plan to use the cohorts as a platform 
for their evaluation, by linking dates and presence of 
interventions as data become available. There are subtle 
differences in the timing and approaches to controlling 
the epidemic in diverse settings and in exiting lockdown 
across the four UK nations. This provides opportunities 
for collaborative and timely evaluation of natural exper-
iments of policies and approaches across the UK, which 
would refine evidence- based exit strategies. We are also 
keen to contribute to international initiatives.
Patient and public involvement
This study is based on an extension of the developing 
Wales Multimorbidity Cohort (WMC). CD and JD are 
members of the public who were involved in the design 
of the WMC and C20/C16 studies. Additional members 
of the public are in the process of being recruited to the 
research steering committee to represent the views of 
health, social care and educational staff.
ETHICS AND DISSEMINATION
SAIL’s independent Information Governance Review 
Panel (IGRP)5 has approved a submission to allow the use 
of WMC with additional data flows to aid the COVID-19 
research response (SAIL project 0911). IGRP applica-
tions are scrutinised by members of the public; only those 
applications that can demonstrate privacy protection and 
are in the public interest are approved. SAIL’s Consumer 
Panel, comprising members of the public, were consulted 
during the development of WMC. Two members of 
the public were recruited to the study steering group 
following approval.
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